###### Strengths and limitations of this study

-   This is the first quantitative review and meta-analysis of cohort evidence for long-term exposure to ozone and a range of causes of death.

-   Fourteen publications from eight cohorts were identified. The majority of cohorts were from the USA and most of these focused on selected population subgroups.

-   We found no evidence of associations between long-term annual O~3~ concentrations and the risk of death. Studies that used O~3~ concentrations measured during the warmer months as the exposure metric generally reported positive associations, especially with respiratory mortality.

-   Climate change and increasing anthropogenic emissions of ozone precursors on ozone levels worldwide is likely to increase the population exposure to ozone. For the impact of these changes on mortality to be estimated further, cohort studies in representative populations utilising comparable ozone metrics are required.

Introduction {#s1}
============

Outdoor air pollution comprises a mixture of particles and gases and has been associated with a range of acute and chronic health effects.[@R1] An important component of this mixture of pollutants is ozone (O~3~), a gaseous pollutant formed by atmospheric chemical reactions involving nitrogen oxides (NO~x~) and volatile organic compound precursor gas emissions, and driven by solar radiation and temperature.[@R2] [@R3] Ozone is a highly reactive, oxidative gas and the concentrations of O~3~ at a given time and place are also determined by the rate of loss through chemical reactions, the rate of surface deposition and long-range atmospheric transport processes which can vary with season and meteorological conditions. Climate change, as well as changes in anthropogenic emissions of O~3~ precursors, is likely to have an effect on ground-level O~3~ concentrations in the future.[@R4] [@R5]

The highly reactive nature of O~3~ initiates oxidative stress when it enters the respiratory tract.[@R2] Epidemiological studies have demonstrated adverse associations between short-term exposure to O~3~ and human health including reduced respiratory function and increased hospital admissions and deaths from respiratory diseases.[@R1] [@R2] Associations between short-term exposure to O~3~ and cardiovascular mortality have also been reported; however, associations with cardiovascular morbidity are less convincing.[@R6]

In contrast to the evidence from short-term exposure studies, the evidence for adverse health effects associated with long-term exposure to O~3~, that is, average exposure measured over years, is mixed. The 2005 global update to the WHO air quality guidelines[@R7] did not find support for an association with mortality. In their update of the 2006 Air Quality Criteria Document,[@R8] the US Environmental Protection Agency (EPA) concluded that there was evidence suggestive of an association with respiratory mortality but limited support for an association with total and cardiopulmonary mortality,[@R6] a view endorsed by the comprehensive review of the evidence in support of the revision of the European Union\'s (EU) air quality policies.[@R1] While both of these reviews covered a wide range of possible health effects, both excluded recent large cohort studies in the UK[@R9] and the USA.[@R10] Furthermore, both reviews presented a narrative assessment of the evidence and did not attempt a quantitative evaluation of hazard or meta-analysis.

There is an important need to develop better concentration response functions that can be used in health impact assessments such as the Global Burden of Disease[@R11] and for modelling the potential ozone impacts associated with climate change. In this review, we present a quantitative evaluation of the evidence from cohort studies published in the peer-reviewed literature to October 2015, reporting associations between long-term exposure to ozone and mortality. We also assess the evidence stratified by cause of death, during the 'warm season' and after adjustment for fine particle concentrations.

Materials and methods {#s2}
=====================

Systematic ascertainment of cohort studies {#s2a}
------------------------------------------

Cohort studies published in peer-reviewed journals were identified from searches of EMBASE (between 1974 and week 40 2015) and MEDLINE (1946 to September week 4 2015) within Ovid. Three search strings, relating to study design, health outcome and pollutant were used without language restriction (provided in the [online supplementary material](#SM1){ref-type="supplementary-material"}). Studies identified in each search were combined and duplicates (241) removed within Ovid.
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A screening process to identify cohort studies assessing associations between long-term exposure to ozone and mortality was applied to the remaining 277 records. This process used the study title and abstract to identify potential studies for which the full paper was downloaded and checked. Exclusion criteria related to: (1) article type, (2) study design, (3) outcome, (4) exposure, and (5) use of individual rather than ecological covariates and further details of these criteria are provided in the [online supplementary material](#SM1){ref-type="supplementary-material"}. A total of 253 records were deleted. The main reasons for removal were: conference abstracts/notes, reviews, not cohort design and no ozone data in study. The literature searching and screening was undertaken by BKB.

We also conducted a separate search of PubMed (6 October 2015), undertaken by RWA and using three similar search terms (provided in the [online supplementary material](#SM1){ref-type="supplementary-material"}). Studies identified in each PubMed search were downloaded to Reference Manager databases (2014 Thomson Reuters) which were then combined and duplicates identified and removed. Two publications, additional to those returned in the Ovid searches, were identified. One study was published subsequent to the Ovid search date[@R12] and the second was a reanalysis of an existing cohort with a focus on particulate matter.[@R13] Finally, we included three known potentially relevant early publications.[@R14] In total, 29 cohort studies were available for detailed evaluation to determine their inclusion in our review.

Each study was then further assessed against inclusion/exclusion criteria relating to covariate adjustment and provision of quantitative data to facilitate standardisation of hazard ratio (HR). Details of these exclusion/inclusion criteria are also given in the [online supplementary material](#SM1){ref-type="supplementary-material"}. Seven cohort studies did not include adjustment for key confounders (age, sex, body mass index, smoking and socioeconomic status) and were excluded.[@R17] Five studies[@R14] [@R16] [@R24] did not provide numerical values for HRs and associated 95% CIs together with the necessary data to enable standardisation of the HR (to an increment of 10 ppb). We do, however, note the qualitative findings from these studies. One study of respiratory mortality[@R27] included contributory respiratory causes of death as well as underlying causes and was not included in our quantitative assessment of the evidence because of this non-standard definition of cause of death. Finally, two studies[@R13] [@R28] duplicated data presented in other publications[@R15] [@R29] and were excluded. Hence, 14 studies met our inclusion/exclusion criteria and were included in our quantitative review.[@R9] [@R10] [@R12] [@R15] [@R26] [@R29] The process, together with the numbers of studies identified at each stage, is illustrated in [figure 1](#BMJOPEN2015009493F1){ref-type="fig"}.[@R38]

![Overview of ascertainment of studies.](bmjopen2015009493f01){#BMJOPEN2015009493F1}

Data extraction and coding {#s2b}
--------------------------

For each cohort study, the following details were extracted: (1) citation details (title, authors, date of publication, etc); (2) cohort details including study location (country/city), study population, follow-up period(s), confounder adjustment; (3) details of the effect estimates including diagnosis, unit of measurement, concentration range for HR, metric description (annual mean, etc), period of year for exposure assessment (either all-year or 'warm season' according to the definition used in the original studies). These data were used to characterise/describe each cohort and to calculate standardised HRs and 95% confidence interval (CI) expressed per 10 ppb increase in O~3~ concentration. Where necessary, estimates reported in µg/m^3^ were converted to ppb using 1 ppb=2 µg/m^3^ at an ambient pressure of 1 atm and a temperature of 25°C. This process was undertaken by BKB and checked by RWA.

The STATA program 'metan' was used to produce forest plots and to undertake random-effects meta-analysis where three or more estimates from separate cohorts were available for a specific cause of death. Where a cohort was analysed more than once, the estimate from the most recent study analysed, the largest sample size, most recent exposure and follow-up periods was selected for inclusion in the meta-analysis. This process ensured the size and direction the HRs reported in the studies did not influence their selection for meta-analysis, therefore limiting the potential for selection bias.

Results {#s3}
=======

Our literature search identified 14 publications from eight cohorts reporting HRs for ozone and mortality and associated data to enable standardisation. Key characteristics of each study are summarised in the [online supplementary material](#SM1){ref-type="supplementary-material"}. Six cohorts focused on selected population subgroups: Seventh Day Adventists non-Hispanic white non-smokers (Adventist Health Study of Smog; AHSMOG), white participants (six cities), male veterans with diagnosed hypertension (Washington University - Electric Power Research Institute Veterans Cohort; WU-EPRI), and three selected occupation cohorts: female teachers (California Teachers Study; CTS), energy workers (Gazel) and Taiwanese civil servants. The American Cancer Society Cancer Prevention Study II (ACS CPS II) cohort was comprised of mainly friends, neighbours, acquaintances and relatives of volunteer recruiters. One study used administrative data to construct a primary care cohort (CPRD). The majority of cohorts (5/8) and publications (11/14) were from the USA with the ACS CPS II cohort analysed in five separate publications. In total, 12/14 studies assessed associations with all-cause mortality and 11/14 cause-specific mortality. Summer or peak O~3~ measures were assessed in 8/14 studies, and 8/14 studies reported associations adjusted for mass of particles with a median aerodynamic diameter \<2.5 µm (PM~2.5~).

All season {#s3a}
----------

Standardised effect estimates, expressed as the HR (95% CI) per 10 ppb increase in O~3~, for all-cause and cause-specific mortality are shown in the forest plot in [figure 2](#BMJOPEN2015009493F2){ref-type="fig"}, and random-effects summary estimates are presented in [table 1](#BMJOPEN2015009493TB1){ref-type="table"}. We found no evidence of an association between long-term annual O~3~ concentrations and the risk of death from all causes. Meta-analysis of the seven HRs from the six cohorts gave a summary HR=0.96 (95% CI 0.92 to 1.00) per 10 ppb increase in O~3~ with evidence of heterogeneity (I^2^=81%). Similarly, we did not find evidence for associations between long-term annual O~3~ concentrations and deaths from cardiovascular, ischaemic heart disease (IHD), cardiopulmonary and respiratory diseases and lung cancer ([table 1](#BMJOPEN2015009493TB1){ref-type="table"}).

###### 

Meta-analytic summary estimates by cause of death

  Cause of death             Study citation                             Number of estimates   HR (95% CI)           I^2^ (%)\*
  -------------------------- ------------------------------------------ --------------------- --------------------- ------------
  All year                                                                                                          
   All causes                [@R9] [@R15] [@R29] [@R30] [@R34] [@R36]   7†                    0.96 (0.92 to 1.00)   81
   Cardiovascular            [@R9] [@R12] [@R32] [@R36]                 5†                    0.98 (0.93 to 1.04)   55
   Ischaemic heart disease   [@R9] [@R29] [@R36]                        3                     1.00 (0.92 to 1.09)   72
   Cardiopulmonary           [@R15] [@R29] [@R30]                       4†                    0.98 (0.90 to 1.07)   59
   Respiratory               [@R9] [@R10] [@R36]                        3                     0.94 (0.81 to 1.10)   84
   Lung cancer               [@R9] [@R15] [@R29] [@R30] [@R36]          6†                    0.95 (0.83 to 1.08)   55
  Warm season/peak ozone                                                                                            
   All causes                [@R29] [@R34] [@R36] [@R37]                4                     1.00 (0.99 to 1.02)   46
   Cardiovascular            [@R26] [@R36] [@R37]                       3                     1.01 (1.00 to 1.02)   0
   Respiratory               [@R26] [@R36] [@R37]                       3                     1.03 (1.01 to 1.05)   0

HRs expressed per 10 ppb increase in O~3~.

\*I^2^ statistic.

†Separate estimates for male and female members of AHSMOG cohort; hence, number of cohorts is one less that the number of estimates in the meta-analysis.

![RR (95% CI) of death per 10 ppb increase in long-term exposure to ozone. ACS CPS II, American Cancer Society Cancer Prevention Study II; AHSMOG, Adventist Health Study of Smog; CTS, California Teachers Study; IHD, ischaemic heart disease; RR, relative risk; WU-EPRI, Washington University - Electric Power Research Institute Veterans Cohort.](bmjopen2015009493f02){#BMJOPEN2015009493F2}

Warm season {#s3b}
-----------

O~3~ concentrations during the 'warm season' (defined either as the period April to September or July to September or by selecting peak annual concentrations) were reported in the ACS CPS II, CTS, WU-EPRI and Gazel cohorts ([figure 3](#BMJOPEN2015009493F3){ref-type="fig"}). HRs for all-cause mortality were generally close to unity with 95% CI that encompassed unity. Associations for cardiopulmonary and respiratory causes of death were more convincing with HRs in the range 1.01--1.02 and 1.02--1.04, respectively, with lower confidence limits close to 1 other than for the French Gazel cohort. Summary HRs derived from meta-analysis of three or more cohorts ([table 1](#BMJOPEN2015009493TB1){ref-type="table"}) showed no association with all-cause mortality but positive associations with cause-specific mortality, respiratory in particular. The reanalysis of the ACS CPS II cohort by Jerrett *et al*,[@R26] included almost 500 000 participants across the USA and reported a HR for respiratory mortality of 1.03 (95% CI 1.01 to 1.05) per 10 ppb increase in the average daily maximum 1 h ozone concentrations measured between April and September. They also considered the impact of adjusting for ambient temperature in 90 of the 96 metropolitan statistical areas and found no material difference in the O~3~ HR. Finally, the authors assessed the shape of the concentration--response function and found no evidence that a threshold model specification improved model fit when compared with a non-threshold linear model.

![RR (95% CI) of death per 10 ppb increase in long-term 'warm-season' ozone exposure. ACS CPS II, American Cancer Society Cancer Prevention Study II; IHD, ischaemic heart disease; RR, relative risk; WU-EPRI, Washington University - Electric Power Research Institute Veterans Cohort.](bmjopen2015009493f03){#BMJOPEN2015009493F3}

Adjustment for PM~2.5~ {#s3c}
----------------------

O~3~ concentrations and death from a range of diseases adjusted for concentrations of fine particles (PM~2.5~) were studied in five cohorts (ACS CPS II, CTS, CPRD, WU-EPRI and Gazel) though the bulk of the evidence was from the ACS ([figure 4](#BMJOPEN2015009493F4){ref-type="fig"}). Results from these studies do not suggest a positive association between O~3~ and all-cause or cause-specific mortality, other than the single estimate for respiratory mortality from the ACS CPS II cohort.[@R26]

![RR (95% CI) of death per 10 ppb increase in long-term ozone exposure, adjusted for long-term exposure to PM~2.5~. Note: For Krewski 2009, ozone increment assumed to be 10 ppb. ACS CPS II, American Cancer Society Cancer Prevention Study II; CTS, California Teachers Study; IHD, ischaemic heart disease; WU-EPRI, Washington University - Electric Power Research Institute Veterans Cohort; RR, relative risk; PM~2.5~, mass of particles with a median aerodynamic diameter less than 2.5 µm.](bmjopen2015009493f04){#BMJOPEN2015009493F4}

Qualitative studies {#s3d}
-------------------

Four of the five studies that did not provide numerical data to enable the standardisation of the HR and CIs and hence inclusion in our quantitative review found no evidence of statistically significant associations with mortality.[@R14] [@R16] [@R25] [@R39] The fifth study reported elevated significant overall associations with mortality.[@R24]

Discussion {#s4}
==========

This quantitative systematic review of the evidence for an association between long-term exposure to O~3~ and an increased risk of death identified a small literature base dominated by US studies and the ACS CPS II cohort in particular. We found no evidence of associations between long-term annual O~3~ concentrations and the risk of death. Studies that used O~3~ concentrations measured during the warmer months or peak ozone (95% centile of daily maximum 1 h ozone) as the exposure metric generally reported positive associations, especially with cardiopulmonary and respiratory mortality.

Previous reviews of the health effects of long-term exposure to O~3~ have provided narrative assessments of the cohort literature as part of comprehensive assessments of the epidemiological and toxicological evidence.[@R1] [@R6] Prueitt *et al*[@R40] utilised the studies identified in the EPA review as a basis for a weight of evidence analysis for long-term exposure to O~3~ and cardiovascular disease. Cohort studies published since earlier reviews[@R7] [@R8] were examined and revisions to previous concluding statements considered. Our focus on a quantitative analysis of all cohorts, irrespective of publication date, complements the narrative approach by: (1) facilitating an assessment of the number of cohorts, the number of published analyses and reanalyses as well as basic information such as participant characteristics and exposure estimation methods; (2) providing a graphical summary of all of the evidence (in the form of a forest plot) to enable a broad overview of the direction, magnitude and precision of all study findings; and (3) providing, where possible, summary HRs for use in health impact assessment exercises. Concentration response functions from cohort studies have been used previously in burden and impact calculations.[@R11] [@R41] A disadvantage of our quantitative approach is that it does not reflect the diversity between studies in the methods for estimating exposure to O~3~, the definition of potential confounders and the statistical models employed. However, the relatively small number of independent cohorts limits the scope for effect modification analysis with which to explore the relative impact of these important characteristics.

There is also a need for more details of the methods used to determine and assign exposure estimates and statistical models. Some studies used exposure metrics derived from averages, or percentile values, of daily 1 h concentrations and these may not be the most appropriate measure of lower (by definition) long-term average exposures to O~3~. Studies using such metrics may actually be investigating associations with repeat exposures to the highest O~3~ concentrations rather than investigating associations with long-term (ie, cumulative) exposure. However, cohort studies exploit spatial variation in individual exposure estimates and report HRs for an increment in the O~3~ concentrations. Therefore, if the statistical model assumes a linear concentration response function (and most do), then the exact metric used is less important and estimates can be combined in a meta-analysis. However, the selected O~3~ metrics (and the concentrations they represent) may be a source of heterogeneity in any meta-analysis if there is, in reality, a non-linear concentration response function. None-the-less, the exact definition of the exposure metric used in each analysis has an important bearing on the utility of study results in health impact assessment exercises where a concentration response function is applied to a change in pollution concentration.

Our review reveals the paucity of population-based cohorts from which to draw substantive conclusions about the health effects associated with the long-term exposure to O~3~. One cohort comprised participants with pre-existing medical conditions,[@R33] and others selected participants based on employment[@R12] [@R36] [@R37] or specific participant characteristics.[@R30] The ACS CPS II cohort utilised friends, neighbours, acquaintances and relatives of volunteers and is therefore unlikely to be representative of the US general population and the Six Cities cohort is restricted to white participants. Only the English cohort based on an administrative database of patients registered with general practitioners (which is almost universal in the UK) is population based. While studies in selected subgroups support hazard assessment, their findings have limited application in quantifying the risk in the general population. The use of large, linked administrative databases[@R9] may enable a growth in the number of studies reporting results which are nationally representative. There is also a need for cohort studies outside of the USA in order to provide a broader evidence base across a range of O~3~ concentrations and where relationships between O~3~ and co-variables of temperature and other pollutants may be different. This contrasts sharply with the large volume of epidemiological evidence from time-series studies investigating associations from short-term exposure to O~3~.[@R1] This literature incorporates a wide range of health outcomes/diseases and from many regions of the world, including stratification by season. This evidence from short-term exposure studies worldwide does, however, provide support for the application of results from long-term exposure studies in locations with cohort evidence to regions without such evidence.[@R11]

A number of publications using the ACS CPS II cohort have assessed associations between O~3~ concentrations measured during the warmer months of the year and mortality and have reported positive associations with lower confidence limits very close to 1 ([figure 3](#BMJOPEN2015009493F3){ref-type="fig"}). Krewski *et al*[@R29] reported results for O~3~ measured both throughout the year and during April to September. They found stronger associations for cardiopulmonary mortality using measures of O~3~ during the warmer months compared with all year (incorporating comparable confounder adjustment---ref. [@R29], table 3; 1.03 (95% CI 1.02 to 1.04) vs 1.01 (95% CI 1.00 to 1.03) respectively. Similarly, Lipfert *et al*[@R33] reported a positive association between peak exposure (95% centile of daily maximum hourly ozone) and mortality but not with the annual mean. However, this pattern of associations was not observed in a similar comparison using the CTS cohort.[@R36]

The reasons for the modest differences between HRs estimated using warm season and all year concentrations in the ACS CPS II study are not clear. One possibility is that exposure measurement error varies between seasons due to different patterns of human behaviour (eg, time spent outdoors or window opening).[@R42] It may suggest a non-linear concentration response function with larger HRs during the higher ozone concentrations experienced during the warmer months compared with the cooler months of the year though we note that O~3~ in the northern hemisphere can be high earlier in the year. However, the ranges of ozone exposures in the warm and all year periods were not that dissimilar, 11.7--56.4 vs 10.4--41.1 ppb, respectively, although means (30.2 vs 22.9), medians (30.7 vs 22.5) and variances (40.9 vs 21.5) differed substantially.[@R29] An analysis of summer ozone concentrations using the ACS CPS II[@R26] examined the shape of the concentration--response function and did not find evidence that a threshold model specification improved model fit over the linear, non-threshold model. Ozone production during summer episodes is closely related to temperature and solar radiation; hence, the question of whether or not ozone associations observed during the warmer months are independent of the effects of temperature requires investigation. Jerrett *et al*,[@R26] in their analyses of summer ozone concentrations in the USA, found no evidence of confounding by temperature but did report a modifying effect of temperature on the ozone HRs.

Concentrations of ozone at a given time and place are determined not just by its photochemical production, but also the rate of chemical loss, the rate of surface deposition, and of long-range atmospheric transport which vary by season and meteorological conditions. Correlations with other pollutants, including NO~2~ and particles, also vary by season. Therefore, studies of the health effects associated with long-term ozone concentrations should consider, if possible, the numerous complexities involved including (1) seasonal patterns of ozone production/loss; (2) whether relationships are driven by temperature; (3) the shape of the concentration response relationship; and (4) the impact of co-pollutants.

Climate impacts directly or indirectly on many processes that determine the concentrations of ozone at a particular location and time.[@R43] [@R44] Climate-mediated influences on ozone include those related to emission fluxes of ozone precursors, atmospheric chemistry, dispersion and transport, and loss of ozone by dry deposition to vegetation. Climate change may influence future anthropogenic emissions of ozone precursors indirectly through mitigation and adaptation responses, such as reduced energy demand for space heating in winter but greater energy demand for air conditioning in summer. Biogenic emissions of ozone precursors will also be influenced by climate change. For those climate-mediated processes included in model simulations to date, modelling studies[@R4] [@R45] indicate that, overall, the net impact of climate change on surface ozone is generally a decrease in remote (low NO~x~) areas, but an increase in some densely populated (high NO~x~) areas.[@R46] Human exposure to ambient ozone may also be affected by behavioural changes arising from adaptive strategies.[@R47] Studies of long-term exposure to ozone may therefore have increasing relevance in the future if concentrations of ozone rise in densely populated urban areas.

Our quantitative review of the literature revealed a paucity of independent, population-based studies regarding the effects of long-term exposure to ozone on mortality. Furthermore, the evidence from outside the USA was very limited. However, there is a suggestion of a modest, adverse association between long-term ozone concentrations measured during the warmer months of the year and cardiopulmonary and respiratory mortality. The need for concentration response functions for burden estimation and evaluation of impacts of climate change will require further large, population-based cohorts utilising comparable ozone metrics.
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